SM

Sabby Management Portfolio holdings

AUM $13M
This Quarter Return
-0.35%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$396M
AUM Growth
+$396M
Cap. Flow
-$33.8M
Cap. Flow %
-8.54%
Top 10 Hldgs %
35.42%
Holding
254
New
59
Increased
32
Reduced
45
Closed
40

Sector Composition

1 Healthcare 57.32%
2 Energy 8.8%
3 Technology 1.44%
4 Communication Services 1.02%
5 Industrials 0.84%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
FOLD icon
176
Amicus Therapeutics
FOLD
$2.42B
0
GILD icon
177
Gilead Sciences
GILD
$140B
0
HALO icon
178
Halozyme
HALO
$8.75B
-191,621
Closed -$2.74M
HCA icon
179
HCA Healthcare
HCA
$95.4B
0
HRTX icon
180
Heron Therapeutics
HRTX
$204M
0
HUM icon
181
Humana
HUM
$37.5B
0
IMUX icon
182
Immunic
IMUX
$79.4M
0
INCY icon
183
Incyte
INCY
$17B
0
INSM icon
184
Insmed
INSM
$30.3B
0
IONS icon
185
Ionis Pharmaceuticals
IONS
$9.64B
0
ITP icon
186
IT Tech Packaging
ITP
$3.51M
0
IWM icon
187
iShares Russell 2000 ETF
IWM
$66.6B
-198,690
Closed -$24.7M
LLY icon
188
Eli Lilly
LLY
$661B
0
LRMR icon
189
Larimar Therapeutics
LRMR
$337M
0
MDGL icon
190
Madrigal Pharmaceuticals
MDGL
$9.7B
-399,000
Closed -$794K
NBIX icon
191
Neurocrine Biosciences
NBIX
$13.5B
0
NVAX icon
192
Novavax
NVAX
$1.2B
0
NVO icon
193
Novo Nordisk
NVO
$252B
0
OEF icon
194
iShares S&P 100 ETF
OEF
$22.1B
0
OMER icon
195
Omeros
OMER
$284M
0
PBYI icon
196
Puma Biotechnology
PBYI
$258M
-9,044
Closed -$2.14M
PFE icon
197
Pfizer
PFE
$141B
0
PGEN icon
198
Precigen
PGEN
$1.42B
0
PRGO icon
199
Perrigo
PRGO
$3.21B
0
PTCT icon
200
PTC Therapeutics
PTCT
$4.41B
0